283 related articles for article (PubMed ID: 15498213)
21. Promoter hypermethylation of mismatch repair genes, hMLH1 and hMSH2 in oral squamous cell carcinoma.
Czerninski R; Krichevsky S; Ashhab Y; Gazit D; Patel V; Ben-Yehuda D
Oral Dis; 2009 Apr; 15(3):206-13. PubMed ID: 19207881
[TBL] [Abstract][Full Text] [Related]
22. Allelic imbalance at the DNA mismatch repair loci, hMSH2, hMLH1, hPMS1, hPMS2 and hMSH3, in squamous cell carcinoma of the head and neck.
Nunn J; Nagini S; Risk JM; Prime W; Maloney P; Liloglou T; Jones AS; Rogers SR; Gosney JR; Woolgar J; Field JK
Oral Oncol; 2003 Feb; 39(2):115-29. PubMed ID: 12509964
[TBL] [Abstract][Full Text] [Related]
23. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on DNA methylation and expression of hMLH1 in ovarian cancer cell line COC1/DDP].
Meng CF; Dai DQ; Guo KJ
Ai Zheng; 2008 Dec; 27(12):1251-5. PubMed ID: 19079988
[TBL] [Abstract][Full Text] [Related]
24. Loss of mismatch repair activity in simian virus 40 large T antigen-immortalized BPH-1 human prostatic epithelial cell line.
Yeh CC; Lee C; Huang MC; Dahiya R
Mol Carcinog; 2001 Jul; 31(3):145-51. PubMed ID: 11479923
[TBL] [Abstract][Full Text] [Related]
25. Aberrant methylation of different DNA repair genes demonstrates distinct prognostic value for esophageal cancer.
Ling ZQ; Li P; Ge MH; Hu FJ; Fang XH; Dong ZM; Mao WM
Dig Dis Sci; 2011 Oct; 56(10):2992-3004. PubMed ID: 21674174
[TBL] [Abstract][Full Text] [Related]
26. Methylation of the hMLH1 promoter and its association with microsatellite instability in acute myeloid leukemia.
Seedhouse CH; Das-Gupta EP; Russell NH
Leukemia; 2003 Jan; 17(1):83-8. PubMed ID: 12529664
[TBL] [Abstract][Full Text] [Related]
27. Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence.
Lee KH; Lee JS; Nam JH; Choi C; Lee MC; Park CS; Juhng SW; Lee JH
Langenbecks Arch Surg; 2011 Oct; 396(7):1017-26. PubMed ID: 21706233
[TBL] [Abstract][Full Text] [Related]
28. DNA mismatch repair enzyme activity and gene expression in prostate cancer.
Yeh CC; Lee C; Dahiya R
Biochem Biophys Res Commun; 2001 Jul; 285(2):409-13. PubMed ID: 11444857
[TBL] [Abstract][Full Text] [Related]
29. Methylation status of genes upregulated by demethylating agent 5-aza-2'-deoxycytidine in hepatocellular carcinoma.
Hirasawa Y; Arai M; Imazeki F; Tada M; Mikata R; Fukai K; Miyazaki M; Ochiai T; Saisho H; Yokosuka O
Oncology; 2006; 71(1-2):77-85. PubMed ID: 17341888
[TBL] [Abstract][Full Text] [Related]
30. Mismatch repair genes (hMLH1, hPMS1, hPMS2, GTBP/hMSH6, hMSH2) in the pathogenesis of hepatocellular carcinoma.
Zekri AR; Sabry GM; Bahnassy AA; Shalaby KA; Abdel-Wahabh SA; Zakaria S
World J Gastroenterol; 2005 May; 11(20):3020-6. PubMed ID: 15918183
[TBL] [Abstract][Full Text] [Related]
31. Methylation of hMLH1 in a population-based series of endometrial carcinomas.
Salvesen HB; MacDonald N; Ryan A; Iversen OE; Jacobs IJ; Akslen LA; Das S
Clin Cancer Res; 2000 Sep; 6(9):3607-13. PubMed ID: 10999752
[TBL] [Abstract][Full Text] [Related]
32. Microsatellite instability is associated with genetic alteration but not with low levels of expression of the human mismatch repair proteins hMSH2 and hMLH1.
Shin KH; Park JG
Eur J Cancer; 2000 May; 36(7):925-31. PubMed ID: 10785599
[TBL] [Abstract][Full Text] [Related]
33. Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter.
Plumb JA; Strathdee G; Sludden J; Kaye SB; Brown R
Cancer Res; 2000 Nov; 60(21):6039-44. PubMed ID: 11085525
[TBL] [Abstract][Full Text] [Related]
34. Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene.
Shin KH; Shin JH; Kim JH; Park JG
Cancer Res; 2002 Jan; 62(1):38-42. PubMed ID: 11782355
[TBL] [Abstract][Full Text] [Related]
35. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma.
Herman JG; Umar A; Polyak K; Graff JR; Ahuja N; Issa JP; Markowitz S; Willson JK; Hamilton SR; Kinzler KW; Kane MF; Kolodner RD; Vogelstein B; Kunkel TA; Baylin SB
Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6870-5. PubMed ID: 9618505
[TBL] [Abstract][Full Text] [Related]
36. Methylation in hMLH1 promoter interferes with its binding to transcription factor CBF and inhibits gene expression.
Deng G; Chen A; Pong E; Kim YS
Oncogene; 2001 Oct; 20(48):7120-7. PubMed ID: 11704838
[TBL] [Abstract][Full Text] [Related]
37. Promoter methylation and expression of DNA repair genes hMLH1 and MGMT in acute myeloid leukemia.
Lenz G; Hutter G; Hiddemann W; Dreyling M
Ann Hematol; 2004 Oct; 83(10):628-33. PubMed ID: 15309527
[TBL] [Abstract][Full Text] [Related]
38. High-resolution methylation analysis of the hMLH1 promoter in sporadic endometrial and colorectal carcinomas.
Strazzullo M; Cossu A; Baldinu P; Colombino M; Satta MP; Tanda F; De Bonis ML; Cerase A; D'Urso M; D'Esposito M; Palmieri G
Cancer; 2003 Oct; 98(7):1540-6. PubMed ID: 14508843
[TBL] [Abstract][Full Text] [Related]
39. Estrogen up-regulates mismatch repair activity in normal and malignant endometrial glandular cells.
Miyamoto T; Shiozawa T; Kashima H; Feng YZ; Suzuki A; Kurai M; Nikaido T; Konishi I
Endocrinology; 2006 Oct; 147(10):4863-70. PubMed ID: 16825317
[TBL] [Abstract][Full Text] [Related]
40. Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype.
Sengupta S; Chakrabarti S; Roy A; Panda CK; Roychoudhury S
Cancer; 2007 Feb; 109(4):703-12. PubMed ID: 17219447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
